We are live on ! Find out more
DB

Dmitry Balyasny Balyasny Asset Management

AUM $80.2B
1-Year Est. Return 51.53%
 

Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.

This Fund
S&P 500
This Quarter Est. Return
+1.9%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.37%
10 Year Est. Return
+1,172.21%
AUM
$16.8B
AUM Growth
+$2.43B
Cap. Flow
+$2.2B
Cap. Flow %
13.07%
Top 10 Hldgs %
12.03%
Holding
1,764
New
564
Increased
341
Reduced
326
Closed
526

Top Buys

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$152M
2
T icon
AT&T
T
+$119M
3
NSC icon
Norfolk Southern
NSC
+$117M
4
CSX icon
CSX Corp
CSX
+$115M
5
BKNG icon
Booking.com
BKNG
+$104M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.4%
2 Industrials 9.75%
3 Financials 7.9%
4 Consumer Staples 7.89%
5 Healthcare 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKNG icon
1276
PUT
Booking.com
BKNG
$160B
-250,000
Closed -$12.8M
BLK icon
1277
Blackrock
BLK
$181B
-118,325
Closed -$40.3M
BMA icon
1278
Banco Macro
BMA
$4.9B
-7,500
Closed -$436K
BOKF icon
1279
BOK Financial
BOKF
$8.57B
-4,800
Closed -$287K
BPOP icon
1280
Popular Inc
BPOP
$10.8B
-174,468
Closed -$4.94M
BRK.B icon
1281
Berkshire Hathaway Class B
BRK.B
$1.08T
-4,550
Closed -$601K
BRKR icon
1282
CALL
Bruker
BRKR
$8.74B
-100,000
Closed -$2.43M
BRX icon
1283
Brixmor Property Group
BRX
$9.04B
-23,799
Closed -$614K
BSX icon
1284
Boston Scientific
BSX
$70.8B
-811,023
Closed -$15M
BUD icon
1285
AB InBev
BUD
$156B
-226,642
Closed -$28.3M
BURL icon
1286
CALL
Burlington
BURL
$20.6B
-100,000
Closed -$4.29M
BXP icon
1287
Boston Properties
BXP
$11.1B
-19,245
Closed -$2.46M
NXH
1288
Neighborhood Intelligence Inc
NXH
$371M
-19,433
Closed -$179K
CAL icon
1289
Caleres
CAL
$456M
-81,709
Closed -$2.19M
CBRL icon
1290
Cracker Barrel
CBRL
$1.3B
-2,130
Closed -$270K
CCL icon
1291
Carnival Corporation Ltd
CCL
$35.3B
-177,658
Closed -$8.6M
CDP icon
1292
COPT Defense Properties
CDP
$4.24B
-510,592
Closed -$11.1M
CF icon
1293
CF Industries
CF
$19.5B
-120,000
Closed -$4.9M
CFR icon
1294
PUT
Cullen/Frost Bankers
CFR
$10.2B
-50,000
Closed -$3M
CHKP icon
1295
CALL
Check Point Software Technologies
CHKP
$13.4B
-150,000
Closed -$12.2M
CLLS
1296
Cellectis
CLLS
$321M
-57,162
Closed -$1.77M
CLMT icon
1297
Calumet Specialty Products
CLMT
$4.11B
-85,200
Closed -$1.7M
CLX icon
1298
Clorox
CLX
$13.1B
-115,442
Closed -$14.6M
CMA
1299
DELISTED
Comerica
CMA
-458,612
Closed -$16.5M
CMG icon
1300
CALL
Chipotle Mexican Grill
CMG
$47.9B
-3,150,000
Closed -$30.2M

Similar funds

Dmitry Balyasny's Q1 2016 Portfolio in Review

As of Q1 2016, Dmitry Balyasny held 1,764 positions worth $16.8B, up 17% from $14.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Dmitry Balyasny deployed $2.2B of net new capital in Q1 2016, opening 564 new positions and adding to 341 existing holdings. Its largest new stake was Norfolk Southern: 1,546,641 shares worth $129M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $187M trimmed.

  • Dmitry Balyasny's largest Q1 2016 buy was Norfolk Southern: 1,546,641 shares worth $129M.
  • Dmitry Balyasny added most to Marathon Petroleum in Q1 2016, an estimated $152M increase.
  • Dmitry Balyasny's biggest Q1 2016 reduction was Teva Pharmaceuticals, cutting an estimated $187M.
  • Dmitry Balyasny fully exited Union Pacific in Q1 2016, selling an estimated $79.7M.
  • Dmitry Balyasny's ten largest holdings make up 12% of its $16.8B portfolio in Q1 2016.
  • Dmitry Balyasny opened 564 new positions and closed 526 in Q1 2016.
  • Dmitry Balyasny's portfolio value rose 17% quarter-over-quarter to $16.8B.

Based on Balyasny Asset Management's 13F filing for Q1 2016, filed 16 May 2016.